Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil. Clinics, [S. l.], v. 74, p. e771, 2019. DOI: 10.6061/clinics/2019/e771. Disponível em: https://revistas.usp.br/clinics/article/view/162039.. Acesso em: 27 apr. 2024.